Literature DB >> 29266414

Clinical and biological characterization of MPN patients harboring two driver mutations, a French intergroup of myeloproliferative neoplasms (FIM) study.

Olivier Mansier1,2,3, Damien Luque Paz4,5,6,7, Jean-Christophe Ianotto7,8, Yannick Le Bris7,9, Aurélie Chauveau7,10,11,12, Françoise Boyer7,13, Carole Conejero14, Olivier Fitoussi15, Jérémie Riou16, Didier Adiko17, Mohamed Touati18, Jasmine Chauzeix19,20, Jean-François Viallard21, Marie C Béné7,9, Stéphane Giraudier14, Valérie Ugo4,5,6,7, Eric Lippert7,10,11,12.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29266414     DOI: 10.1002/ajh.25014

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

1.  Double-mutant myeloproliferative neoplasms.

Authors:  Stephen E Langabeer
Journal:  Med Oncol       Date:  2018-08-29       Impact factor: 3.064

Review 2.  Genetic Background of Polycythemia Vera.

Authors:  Mathilde Regimbeau; Romain Mary; François Hermetet; François Girodon
Journal:  Genes (Basel)       Date:  2022-04-02       Impact factor: 4.141

3.  A Rare Co-Occurrence of Triple Mutations in JAK2, CALR, and MPL in the Same Patient with Myelofibrosis.

Authors:  Sherine J Thomas; D P Dash
Journal:  Case Rep Hematol       Date:  2022-02-21

4.  A Rare Case of Essential Thrombocythemia with Coexisting JAK2 and MPL Driver Mutations.

Authors:  Mi Ae Jang; Mi Yeon Seo; Kyoung Jin Choi; Dae Sik Hong
Journal:  J Korean Med Sci       Date:  2020-06-15       Impact factor: 2.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.